Screening for obstructive sleep apnoea in obesity and diabetes - potential for future approaches

European Journal of Clinical Investigation

Volumn 43, Issue 6, 2013, Pages 640-655

  Seetho, Ian W ^a   Wilding, John P H ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Diabetes; Obesity; Obstructive sleep apnoea; Screening; Sleep disordered breathing; Type 2

Indexed keywords

8 ISOPROSTANE; BIOLOGICAL MARKER; CYSTEINE; GHRELIN; GLUCOSE; HEMOGLOBIN A1C; HYDROGEN PEROXIDE; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; LEUKOTRIENE B4; NITRATE; NITRIC OXIDE; SELECTIN;

ACTIMETRY; AMERICAN SOCIETY OF ANAESTHESIOLOGISTS QUESTIONNAIRE; ANTHROPOMETRIC PARAMETERS; ARTICLE; ARTIFICIAL NEURAL NETWORK; BERLIN QUESTIONNAIRE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CINICAL DECISION SUPPORT SYSTEM; CORONARY ARTERY DISEASE; DECISION SUPPORT SYSTEM; DIABETES MELLITUS; DISEASE ASSOCIATION; EARLY INTERVENTION; ELECTROENCEPHALOGRAM; EMOTION; EPWORTH SLEEPINESS SCALE; HEALTH CARE UTILIZATION; HEART ATRIUM FIBRILLATION; HEART FAILURE; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; HUMAN RELATION; HYPERTENSION; METABOLIC SYNDROME X; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PLETHYSMOGRAPHY; PORTABLE EQUIPMENT; POSITIVE END EXPIRATORY PRESSURE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; PULSE OXIMETER; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECORDER; SENSITIVITY AND SPECIFICITY; SLEEP DISORDERED BREATHING; SLEEP DISORDERS QUESTIONNAIRE; SOMNOLENCE; STOP BANG QUESTIONNAIRE; STOP QUESTIONNAIRE; SYSTEMATIC REVIEW;

ANTHROPOMETRY; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; EARLY DIAGNOSIS; FORECASTING; HUMANS; METABOLIC SYNDROME X; OBESITY; POINT-OF-CARE SYSTEMS; PROTEOMICS; QUALITY OF LIFE; QUESTIONNAIRES; SLEEP APNEA, OBSTRUCTIVE;

EID: 84877695485     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12083     Document Type: Article

References (133)

1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-1235.
2. Tasali E, Ip MSM. Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. Proc Am Thoracic Soc 2008;5:207-217.
3. Flemons WW, Littner MR, Rowley JA, Gay P, Anderson WM, Hudgel DW et al. Home diagnosis of sleep apnea: a systematic review of the literature. An evidence review cosponsored by the American Academy of Sleep Medicine, the American College of Chest Physicians, and the American Thoracic Society. Chest 2003;124:1543-1579.
4. Caples SM, Gami AS, Somers VK. Obstructive sleep apnea. Ann Intern Med 2005;142:187-197.
5. Flemons WW, Buysse D, Redline S, Pack A, Strohl K, Wheatley J et al. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999;22:667-689.
6. Schwartz AR, Patil SP, Laffan AM, Polotsky V, Schneider H, Smith PL. Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches. Proc Am Thoracic Soc 2008;5:185-192.
7. West SD, Nicoll DJ, Stradling JR. Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax 2006;61:945-950.
8. Foster GD, Sanders MH, Millman R, Zammit G, Borradaile KE, Newman AB et al. Obstructive Sleep Apnea Among Obese Patients With Type 2 Diabetes. Diabetes Care 2009;32:1017-1022.
9. Heffner JE, Rozenfeld Y, Kai M, Stephens EA, Brown LK. Prevalence of diagnosed sleep apnea among patients with type 2 diabetes in primary care. Chest 2012;141:1414-1421.
10. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PMA, Wilding JPH. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004;25:735-741.
11. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 2000;283:1829-1836.
12. Young T, Peppard P, Palta M, Hla KM, Finn L, Morgan B et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997;157:1746-1752.
13. Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 2006;28:596-602.
14. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005;353:2034-2041.
15. Kylintireas I, Craig S, Nethononda R, Kohler M, Francis J, Choudhury R et al. Atherosclerosis and arterial stiffness in obstructive sleep apnea-A cardiovascular magnetic resonance study. Atherosclerosis 2012;222:483-489.
16. Doonan RJ, Scheffler P, Lalli M, Kimoff RJ, Petridou ET, Daskalopoulos ME et al. Increased arterial stiffness in obstructive sleep apnea: a systematic review. Hypertens Res 2011;34:23-32.
17. Hoffstein V, Mateika S. Cardiac-arrhythmias, snoring, and sleep-apnea. Chest 1994;106:466-471.
18. Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL et al. Association of nocturnal arrhythmias with sleep-disordered breathing - The Sleep Heart Health Study. Am J Respir Crit Care Med 2006;173:910-916.
19. Gottlieb DJ, Yenokyan G, Newman AB, O'Connor GT, Punjabi NM, Quan SF et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure the sleep heart health study. Circulation 2010;122:352-360.
20. Chung F, Elsaid H. Screening for obstructive sleep apnea before surgery: why is it important? Curr Opi Anesthesiol 2009;22:405-411.
21. Liao P, Yegneswaran B, Vairavanathan S, Ziberman P, Chung F et al. Postoperative complications in patients with obstructive sleep apnea: a retrospective matched cohort study. Canadian J Anaesth 2009;56:819-828.
22. Ravesloot MJL, van Maanen JP, Hilgevoord AAJ, Van Wagensveld BA, de Vries N. Obstructive sleep apnea is underrecognized and underdiagnosed in patients undergoing bariatric surgery. Eur Arch Otorhinolaryngol 2012;269:1865-1871.
23. Idris I, Hall AP, O'Reilly J, Barnett A, Allen M, Andrew R et al. Obstructive sleep apnoea in patients with type 2 diabetes: aetiology and implications for clinical care. Diabetes Obes Metab 2009;11:733-741.
24. Shaw JE, Punjabi NM, Wilding JP, Alberti KGMM, Zimmet PZ. Sleep-disordered breathing and type 2 diabetes - A report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract 2008;81:2-12.
25. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance - The Sleep Heart Health Study. Am J Epidemiol 2004;160:521-530.
26. Reichmuth KJ, Austin D, Skatrud JB, Young T. Association of sleep apnea and type II diabetes - A population-based study. Am J Respir Crit Care Med 2005;172:1590-1595.
27. Louis M, Punjabi NM. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol 2009;106:1538-1544.
28. Buckley TM, Schatzberg AF. Review: On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: Normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab 2005;90:3106-3114.
29. Spiegel K, Knutson K, Leproult R, Tasali E, Van Cauter E. Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes. J Appl Physiol 2005;99:2008-2019.
30. West SD, Groves DC, Lipinsky HJ, Nicoll DJ, Mason RH, Scanlon PH et al. The prevalence of retinopathy in men with Type 2 diabetes and obstructive sleep apnoea. Diabet Med 2010;27:423-430.
31. Tahrani AA, Ali A, Raymonds NT, Begum S, Dubb K, Mughal S et al. Obstructive sleep apnea and diabetic neuropathy a novel association in patients with type 2 diabetes. Am J Respir Crit Care Med 2012;186:434-441.
32. Hecht L, Mohler R, Meyer G. Effects of CPAP-respiration on markers of glucose metabolism in patients with obstructive sleep apnoea syndrome: a systematic review and meta-analysis. GMS Ger Med Sci 2011;9:Doc20. doi: 10.3205/000143.
33. Surani S, Subramanian S. Effect of continuous positive airway pressure therapy on glucose control. World J Diabetes 2012;3:65-70.
34. Harsch IA, Schahin SP, Radespiel-Troger M, Weintz O, Jahreiss H, Fuchs FS et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004;169:156-162.
35. Weinstock TG, Wang X, Rueschman M, Ismail-Beigi F, Aylor J, Babineau DC et al. A Controlled Trial of CPAP Therapy on Metabolic Control in Individuals with Impaired Glucose Tolerance and Sleep Apnea. Sleep 2012;35:617-625.
36. Babu AR, Herdegen J, Fogelfeld L, Shott S, Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 2005;165:447-452.
37. West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling JR. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 2007;62:969-974.
38. Pepin JL, Tamisier R, Levy P. Obstructive sleep apnoea and metabolic syndrome: put CPAP efficacy in a more realistic perspective. Thorax 2012;67:1025-1027.
39. Vgontzas AN, Bixier EO, Chrousos GP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 2005;9:211-224.
40. Coughlin SR, Mawdsley L, Mugarza JA, Wilding JPH, Calverley PMA. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J 2007;29:720-727.
41. Haentjens P, Van Meerhaeghe A, Moscariello A, De Weerdt S, Poppe K, Dupont A et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome - Evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 2007;167:757-765.
42. Sharma SK, Agrawal S, Damodaran D, Sreenivas V, Kadhiravan T, Lakshmy R et al. CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med 2011;365:2277-2286.
43. Veasey SC, Guilleminault C, Strohl KP, Sanders MH, Ballard RD, Magalang UJ. Medical therapy for obstructive sleep apnea: a review by the medical therapy for obstructive sleep apnea task force of the standards of practice committee of the American academy of sleep medicine. Sleep 2006;29:1036-1044.
44. Foster GD, Borradaile KE, Sanders MH, Millman R, Zammit G, Newman AB et al. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes the sleep AHEAD Study. Arch Intern Med 2009;169:1619-1626.
45. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K et al. Bariatric surgery: A systematic review and meta-analysis. JAMA 2004;292:1724-1737.
46. Dixon JB, Schachter LM, O'Brien PE, Jones K, Grima M, Lambert G et al. Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea a randomized controlled trial. JAMA 2012;308:1142-1149.
47. Marin JM, Carrizo SJ, Vicente E, Agusti AGN. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-1053.
48. Monahan K, Redline S. Role of obstructive sleep apnea in cardiovascular disease. Curr Opin Cardiol 2011;26:541-547.
49. Bradley TD, Floras JS. Obstructive sleep apnoea and its cardiovascular consequences. Lancet 2009;373:82-93.
50. Drager LF, Bortolotto LA, Maki-Nunes C, Trombetta IC, Alves M, Fraga RF et al. The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome. Atherosclerosis 2010;208:490-495.
51. Marin JM, Agusti A, Villar I, Forner M, Nieto D, Carrizo SJ et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA 2012;307:2169-2176.
52. Lacasse Y, Godbout C, Series F. Health-related quality of life in obstructive sleep apnoea. Eur Respir J 2002;19:499-503.
53. Young T, Finn L. Epidemiological insights into the public health burden of sleep disordered breathing: sex differences in survival among sleep clinic patients. Thorax 1998;53:S16-S19.
54. Kapur V, Blough DK, Sandblom RE, Hert R, de Maine JB, Sullivan SD et al. The medical cost of undiagnosed sleep apnea. Sleep 1999;22:749-755.
55. Strohl KP, Redline S. Recognition of obstructive sleep apnea. Am J Respir Crit Care Med 1996;154:279-289.
56. Osman EZ, Osborne J, Hill PD, Lee BWV. The Epworth Sleepiness Scale: can it be used for sleep apnoea screening among snorers? Clin Otolaryngol 1999;24:239-241.
57. Dixon JB, Schachter LM, O'Brien PE. Predicting sleep apnea and excessive day sleepiness in the severely obese - Indicators for polysomnography. Chest 2003;123:1134-1141.
58. Riha RL. Clinical assessment of the obstructive sleep apnoea/hypopnoea syndrome. Therap Advan Res Dis 2010;4:83-91.
59. Ward Flemons W, McNicholas WT. Clinical prediction of the sleep apnea syndrome. Sleep Med Rev 1997;1:19-32.
60. Kushida CA, Efron B, Guilleminault C. A predictive morphometric model for the obstructive sleep apnea syndrome. Ann Intern Med 1997; 127: 581.
61. Battagel JM, Johal A, Kotecha B. A cephalometric comparison of subjects with snoring and obstructive sleep apnoea. Eur J Orthod 2000;22:353-365.
62. Ramachandran SK, Josephs LA. A Meta-analysis of clinical screening tests for obstructive sleep apnea. Anesthesiology 2009;110:928-939.
63. Abrishami A, Khajehdehi A, Chung F. A systematic review of screening questionnaires for obstructive sleep apnea. Canadian J Anaesth 2010;57:423-438.
64. Pang KP, Terris DJ. Screening for obstructive sleep apnea: an evidence-based analysis. Am J Otolaryngol 2006;27:112-118.
65. Phillips Respironics. Available at: http://rusleeping.respironincs.com. Accessed on 26 November 2012.
66. Clark AL, Crabbe S, Aziz A, Reddy P, Greenstone M. Use of a screening tool for detection of sleep-disordered breathing. J Laryngol Otol 2009;123:746-749.
67. Ragette R, Wang Y, Weinreich G, Teschler H. Diagnostic performance of single airflow channel recording (ApneaLink) in home diagnosis of sleep apnea. Sleep Breat 2010;14:109-114.
68. de Almeida FR, Ayas NT, Otsuka R, Ueda H, Hamilton P, Ryan FC et al. Nasal pressure recordings to detect obstructive sleep apnea. Sleep Breat 2006;10:62-69.
69. Ng SSS, Chan T-O, To KW, Ngai J, Tung A, Ko FWS et al. Validation of Embletta portable diagnostic system for identifying patients with suspected obstructive sleep apnoea syndrome (OSAS). Respirology 2010;15:336-342.
70. Collop NA, Tracy SL, Kapur V, Mehra R, Kuhlmann D, Fleishman SA et al. Obstructive sleep apnea devices for Out-Of-Center (OOC) Testing: technology evaluation. J Clin Sleep Med 2011;7:531-548.
71. Carpagnano GE, Spanevello A, Sabato R, Depalo A, Palladino GP, Bergantino L et al. Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8. Trans Res 2010;155:35-43.
72. Carpagnano GE, Spanevello A, Sabato R, Depalo A, Turchiarelli V, Barbaro MPF. Exhaled pH, exhaled nitric oxide, and induced sputum cellularity in obese patients with obstructive sleep apnea syndrome. Trans Res 2008;151:45-50.
73. Depalo A, Carpagnano GE, Spanevello A, Sabato R, Cagnazzo MG, Gramiccioni C et al. Exhaled NO and iNOS expression in sputum cells of healthy, obese and OSA subjects. J Intern Med 2008;263:70-78.
74. Olopade CO, Christon JA, Zakkar M, Hua CW, Swedler WI, Scheff PA et al. Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea. Chest 1997;111:1500-1504.
75. Petrosyan M, Perraki E, Simoes D, Koutsourelakis I, Vagiakis E, Roussos C et al. Exhaled breath markers in patients with obstructive sleep apnoea. Sleep Breat 2008;12:207-215.
76. Bucca C, Brussino L, Maule MM, Baldi I, Guida G, Culla B et al. Clinical and functional prediction of moderate to severe obstructive sleep apnoea. Clinical Res J 2011;5:219-226.
77. Montesi SB, Bajwa EK, Malhotra A. Biomarkers of sleep apnea. Chest 2012;142:239-245.
78. Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. Plos Medicine 2004;1:210-217.
79. Arnardottir ES, Mackiewicz M, Gislason T, Teff KL, Pack AI. Molecular Signatures of Obstructive Sleep Apnea in Adults: A Review and Perspective. Sleep 2009;32:447-470.
80. Polotsky VY, O'Donnell CP. Genomics of sleep-disordered breathing. Proc Am Thoracic Soc 2007;4:121-126.
81. Gozal D, Jortani S, Snow AB, Kheirandish-Gozal L, Bhattacharjee R, Kim J et al. Two-dimensional differential in-gel electrophoresis proteomic approaches reveal urine candidate biomarkers in pediatric obstructive sleep apnea. Am J Respir Crit Care Med 2009;180:1253-1261.
82. Krishna J, Shah ZA, Merchant M, Klein JB, Gozal D. Urinary protein expression patterns in children with sleep-disordered breathing: Preliminary findings. Sleep Med 2006;7:221-227.
83. Shah ZA, Jortani SA, Tauman R, Valdes R, Gozal D. Serum proteomic patterns associated with sleep-disordered breathing in children. Pediatr Res 2006;59:466-470.
84. Snow A, Gozal D, Valdes R, Jortani SA. Urinary proteins for the diagnosis of obstructive sleep apnea syndrome. Urinary Prot: Methods and Protocols A. J. Rai. 2010;641:223-241.
85. Jurado-Gamez B, Gomez-Chaparro JL, Munoz-Calero M, Sanz AS, Munoz-Cabrera L, Lopez-Barea J et al. Serum proteomic changes in adults with obstructive sleep apnoea. J Sleep Res 2012;21:139-146.
86. Mischak H. How to get proteomics to the clinic? Issues in clinical proteomics, exemplified by CE-MS. Proteo Clin Appl 2012;6: 437-+.
87. Mischak H, Ioannidis JP, Argiles A, Attwood TK, Bongcam-Rudloff E, Broenstrup M et al. Implementation of proteomic biomarkers: making it work. Eur J Clin Invest 2012;42:1027-1036.
88. Pouliot Z, Peters M, Neufeld H, Kryger MH. Using self-reported questionnaire data to prioritize OSA patients for polysomnography. Sleep 1997;20:232-236.
89. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999;131: 485-491.
90. Sharma SK, Vasudev C, Sinha S, Banga A, Pandey RM, Handa KK. Validation of the modified Berlin questionnaire to identify patients at risk for the obstructive sleep apnoea syndrome. Indian J Med Res 2006;124:281-290.
91. Ahmadi N, Chung SA, Gibbs A, Shapiro CM. The Berlin questionnaire for sleep apnea in a sleep clinic population: relationship to polysomnographic measurement of respiratory disturbance. Sleep Breat 2008;12:39-45.
92. Silva GE, Vana KD, Goodwin JL, Sherrill DL, Quan SF. Identification of patients with sleep disordered breathing: comparing the four-variable screening tool, STOP, STOP-Bang, and Epworth Sleepiness Scales. J Clin Sleep Med 2011;7:467-472.
93. Chung F, Yegneswaran B, Liao P, Chung SA, Vairavanathan S, Islam S et al. STOP questionnaire - a tool to screen patients for obstructive sleep apnea. Anesthesiology 2008;108:812-821.
94. Chung F, Yegneswaran B, Liao P, Chung SA, Vairavanathan S, Islam S et al. Validation of the Berlin questionnaire and American Society of Anesthesiologists checklist as screening tools for obstructive sleep apnea in surgical patients. Anesthesiology 2008;108:822-830.
95. Weatherwax KJ, Lin XH, Marzec ML, Malow BA. Obstructive sleep apnea in epilepsy patients: the Sleep Apnea scale of the Sleep Disorders Questionnaire (SA-SDQ) is a useful screening instrument for obstructive sleep apnea in a disease-specific population. Sleep Med 2003;4:517-521.
96. Kirby SD, Danter W, George CFP, Francovic T, Ruby RRF, Ferguson KA. Neural network prediction of obstructive sleep apnea from clinical criteria. Chest 1999;116:409-415.
97. El-Solh AA, Mador MJ, Ten-Brock E, Shucard DW, Abul-Khoudoud M, Grant BJB. Validity of neural network in sleep apnea. Sleep 1999;22:105-111.
98. Tsai WH, Remmers JE, Brant R, Flemons WW, Davies J, Macarthur C. A decision rule for diagnostic testing in obstructive sleep apnea. Am J Respir Crit Care Med 2003;167:1427-1432.
99. Laporta R, Anandam A, El-Solh AA. Screening for obstructive sleep apnea in veterans with ischemic heart disease using a computer-based clinical decision-support system. Clin Res Cardiol 2012;101:737-744.
100. Chen H, Lowe AA, Bai Y, Hamilton P, Fleetham JA, Almeida FR. Evaluation of a portable recording device (ApneaLink (TM)) for case selection of obstructive sleep apnea. Sleep Breat 2009;13:213-219.
101. Grover SS, Pittman SD. Automated detection of sleep disordered breathing using a nasal pressure monitoring device. Sleep Breat 2008;12:339-345.
102. Watkins MR, Talmage JB, Thiese MS, Hudson TB, Hegmann KT. Correlation between screening for obstructive sleep apnea using a portable device versus polysomnography testing in a commercial driving population. J Occup Environ Med 2009;51:1145-1150.
103. Driver HS, Pereira EJ, Bjerring K, Toop F, Stewart SC, Munt PW et al. Validation of the MediByte (R) type 3 portable monitor compared with polysomnography for screening of obstructive sleep apnea. Canadian Res J 2011;18:137-143.
104. Nakano H, Tanigawa T, Ohnishi Y, Uemori H, Senzaki K, Furukawa T et al. Validation of a single-channel airflow monitor for screening of sleep-disordered breathing. Eur Respir J 2008;32:1060-1067.
105. Golpe R, Jimenez A, Carpizo R. Home sleep studies in the assessment of sleep apnea/hypopnea syndrome. Chest 2002;122:1156-1161.
106. Garcia-Diaz E, Quintana-Gallego E, Ruiz A, Carmona-Bernal C, Sanchez-Armengol A, Botebol-Benhamou G et al. Respiratory polygraphy with actigraphy in the diagnosis of sleep apnea-hypopnea syndrome. Chest 2007;131:725-732.
107. Takama N, Kurabayashi M. Effectiveness of a portable device and the need for treatment of mild-to-moderate obstructive sleep-disordered breathing in patients with cardiovascular disease. J Cardiol 2010;56:73-78.
108. Ayappa I, Norman RG, Seelall V, Rapoport DM. Validation of a self-applied unattended monitor for sleep disordered breathing. Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine 2008;4:26-37.
109. Westbrook PR, Levendowski DJ, Cvetinovic M, Zavora T, Velimirovic V, Henninger D et al. Description and validation of the apnea risk evaluation system - a novel method to diagnose sleep apnea-hypopnea in the home. Chest 2005;128:2166-2175.
110. Santos-Silva R, Sartori DE, Truksinas V, Truksinas E, D Alonso FFF, Tufik S et al. Validation of a portable monitoring system for the diagnosis of obstructive sleep apnea syndrome. Sleep 2009;32:629-636.
111. Campbell AJ, Neill AM. Home set-up polysomnography in the assessment of suspected obstructive sleep apnea. J Sleep Res 2011;20:207-213.
112. Choi JH, Kim EJ, Kim YS, Choi J, Kim TH, Kwon SY et al. Validation study of portable device for the diagnosis of obstructive sleep apnea according to the new AASM scoring criteria: Watch-PAT 100. Acta Otolaryngol 2010;130:838-843.
113. Heneghan C, de Chazal P, Ryan S, Chua C-P, Doherty L, Boyle P et al. Electrocardiogram recording as a screening tool for sleep disordered breathing. J Clin Sleep Med 2008;4:223-228.
114. Reichert JA, Bloch DA, Cundiff E, Votteri BA. Comparison of the NovaSom QSG (TM), a new sleep apnea home-diagnostic system, and polysomnography. Sleep Med 2003;4:213-218.
115. Su S, Baroody FM, Kohrman M, Suskind D. A comparison of polysomnography and a portable home sleep study in the diagnosis of obstructive sleep apnea syndrome. Otolaryngol-Head and Neck Surg 2004;131:844-850.
116. Jobin V, Mayer P, Bellemare F. Predictive value of automated oxygen saturation analysis for the diagnosis and treatment of obstructive sleep apnoea in a home-based setting. Thorax 2007;62:422-427.
117. Agatsuma T, Fujimoto K, Komatsu Y, Urushihata K, Honda T, Tsukahara T et al. A novel device (SD-101) with high accuracy for screening sleep apnoea-hypopnoea syndrome. Respirology 2009;14:1143-1150.
118. Amir O, Barak-Shinar D, Henry A, Smart FW. Photoplethysmography as a single source for analysis of sleep-disordered breathing in patients with severe cardiovascular disease. J Sleep Res 2012;21:94-100.
119. Tiihonen P, Hukkanen T, Tuomilehto H, Mervaala E, Toyras J. Evaluation of a novel ambulatory device for screening of sleep apnea. Telemed J E-Health 2009;15:283-289.
120. Cofta S, Wysocka E, Dziegielewska-Gesiak S, Michalak S, Piorunek T, Batura-Gabryel H et al. Plasma selectins in patients with obstructive sleep apnea. Adv Exp Med Biol 2013;756:113-119.
121. Steiropoulos P, Papanas N, Nena E, Antoniadou M, Serasli E, Papoti S et al. Inflammatory markers in middle-aged obese subjects: does obstructive sleep apnea syndrome play a role? Mediators Inflamm 2010;2010:675320. doi:10.1155/2010/675320.
122. Drager LF, Bortolotto LA, Lorenzi MC, Figueiredo AC, Krieger EM, Lorenzi G. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2005;172:613-618.
123. Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ. Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. Chest 2002;122:1162-1167.
124. Cintra F, Tufik S, D'Almeida V, Calegare BFA, de Paola A, Oliveira W et al. Cysteine a potential biomarker for obstructive sleep apnea. Chest 2011;139:246-252.
125. Aronsohn RS, Whitmore H, Van Cauter E, Tasali E. Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am J Respir Crit Care Med 2010;181:507-513.
126. Babaeizadeh S, Zhou SH, Pittman SD, White DP. Electrocardiogram-derived respiration in screening of sleep-disordered breathing. J Electrocardiol 2011;44:700-706.
127. Adachi H, Mikami A, Kumano-go T, Suganuma N, Matsumoto H, Shigedo Y et al. Clinical significance of pulse rate rise during sleep as a screening marker for the assessment of sleep fragmentation in sleep-disordered breathing. Sleep Med 2003;4:537-542.
128. Hayano J, Watanabe E, Saito Y, Sasaki F, Fujimoto K, Nomiyama T et al. Screening for obstructive sleep apnea by cyclic variation of heart rate. Circ-Arrhythmia Electrophysiol 2011;4:64-72.
129. rdAnnual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society Conference 2011;2011:7731-7734.
130. Abeyratne UR, Wakwella AS, Hukins C. Pitch jump probability measures for the analysis of snoring sounds in apnea. Physiol Meas 2005;26:779-798.
131. Karunajeewa AS, Abeyratne UR, Hukins C. Pitch/Airway-response and cepstral analysis of snore sounds for the non-contact screening of sleep apnea. In: Dossel O, Schlegel WC, editors. World Congress on Medical Physics and Biomedical Engineering, Vol 25, Pt 4: Image Processing, Biosignal Processing, Modelling and Simulation, Biomechanics. New York: Springer; 2010; 25: pp 2295-2298.
132. Gresova S, Tomori Z, Kurpas M, Marossy A, Vrbenska A, Kundrik M et al. Blood pressure increase detected by ambulatory monitoring correlates with hypoxemia reflecting sleep apnea severity. Central Euro J Med 2009;4:222-232.
133. Dillier R, Baumann M, Young M, Erne S, Schwizer B, Zuber M et al. Continuous respiratory monitoring for sleep apnea screening by ambulatory hemodynamic monitor. World J Cardiol 2012;4:121-127.